Skip to main content
Erschienen in: Digestive Diseases and Sciences 7/2011

01.07.2011 | Original Article

Low Grade Esophageal Eosinophilia in Adults: An Unrecognized Part of the Spectrum of Eosinophilic Esophagitis?

verfasst von: Karthik Ravi, Nicholas J. Talley, Thomas C. Smyrk, David A. Katzka, Lori Kryzer, Yvonne Romero, Amindra S. Arora, Jeffrey A. Alexander

Erschienen in: Digestive Diseases and Sciences | Ausgabe 7/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Eosinophilic esophagitis (EoE) is defined by a minimum of 15 eosinophils (eos) per high-powered field (HPF) on esophageal biopsy, along with esophageal symptoms and the exclusion of gastroesophageal reflux (GERD). The clinical significance of fewer eosinophils is unknown.

Methods

Fifty-nine adult patients without a previous diagnosis of EoE with esophageal biopsies containing 1–14 eos per HPF (low grade eosinophilia) and 418 adult patients with ≥15 eos per HPF were identified by retrospective review. Patients were divided into group A (1–9 eos per HPF), group B (10–14 eos per HPF), and group C (≥15 eos per HPF) with a chart review of clinical and demographic data.

Results

While dysphagia and atopy (asthma and allergic rhinitis) were more common in patients with ≥15 eos per HPF (group C) than those with low grade esophageal eosinophilia (groups A and B) (93 vs. 88%, P = 0.02), food impaction and heartburn occurred at an equal frequency across all patient groups. Endoscopic findings were likewise similar between groups. Of the 14 patients with low grade esophageal eosinophilia who underwent repeat endoscopy a mean interval of 42 weeks (range 8–118 weeks) later, five (36%) met conventional diagnostic criteria for EoE of 15 or greater eos per HPF. Follow-up in ten patients treated with topical corticosteroids noted improvement in nine, with mean follow-up of 8 weeks (range 4–12 weeks).

Conclusion

Some adult patients with dysphagia and less than 15 eos per HPF have similar endoscopic findings and clinical course to patients meeting the consensus definition of EoE. Further evaluation of patients with low grade esophageal eosinophilia is needed.
Literatur
1.
Zurück zum Zitat Landres RT, Kuster GG, Strum WB. Eosinophilic esophagitis in a patient with vigorous achalasia. Gastroenterology. 1978;74:1298–1301.PubMed Landres RT, Kuster GG, Strum WB. Eosinophilic esophagitis in a patient with vigorous achalasia. Gastroenterology. 1978;74:1298–1301.PubMed
2.
Zurück zum Zitat Furuta GT, Straumann A. Review article: The pathogenesis and management of eosinophilic oesophagitis. Aliment Pharmacol Ther. 2006;24:173–182.PubMedCrossRef Furuta GT, Straumann A. Review article: The pathogenesis and management of eosinophilic oesophagitis. Aliment Pharmacol Ther. 2006;24:173–182.PubMedCrossRef
3.
Zurück zum Zitat Fox VL, Nurko S, Furuta GT. Eosinophilic esophagitis: It’s not just kid’s stuff. Gastrointest Endosc. 2002;56:260–270.PubMedCrossRef Fox VL, Nurko S, Furuta GT. Eosinophilic esophagitis: It’s not just kid’s stuff. Gastrointest Endosc. 2002;56:260–270.PubMedCrossRef
4.
Zurück zum Zitat Vanderheyden AD, Petras RE, DeYoung BR, et al. Emerging eosinophilic (allergic) esophagitis: Increased incidence or increased recognition? Arch Pathol Lab Med. 2007;131:777–779.PubMed Vanderheyden AD, Petras RE, DeYoung BR, et al. Emerging eosinophilic (allergic) esophagitis: Increased incidence or increased recognition? Arch Pathol Lab Med. 2007;131:777–779.PubMed
5.
Zurück zum Zitat Straumann A, Simon HU. Eosinophilic esophagitis: Escalating epidemiology? J Allergy Clin Immunol. 2005;115:418–419.PubMedCrossRef Straumann A, Simon HU. Eosinophilic esophagitis: Escalating epidemiology? J Allergy Clin Immunol. 2005;115:418–419.PubMedCrossRef
6.
Zurück zum Zitat Noel RJ, Putnam PE, Rothenberg ME. Eosinophilic esophagitis. N Engl J Med. 2004;351:940–941.PubMedCrossRef Noel RJ, Putnam PE, Rothenberg ME. Eosinophilic esophagitis. N Engl J Med. 2004;351:940–941.PubMedCrossRef
7.
Zurück zum Zitat Prasad G, Smyrk T, Schleck C, et al. Secular trends in the epidemiology and outcomes of eosinophilic esophagitis in Olmsted County, Minnesota (1976–2007). Gastroenterology. 2008;134:S1976. Prasad G, Smyrk T, Schleck C, et al. Secular trends in the epidemiology and outcomes of eosinophilic esophagitis in Olmsted County, Minnesota (1976–2007). Gastroenterology. 2008;134:S1976.
8.
Zurück zum Zitat Sgouros SN, Bergele C, Mantides A. Eosinophilic esophagitis in adults: What is the clinical significance? Endoscopy. 2006;38:515–520.PubMedCrossRef Sgouros SN, Bergele C, Mantides A. Eosinophilic esophagitis in adults: What is the clinical significance? Endoscopy. 2006;38:515–520.PubMedCrossRef
9.
Zurück zum Zitat Ferguson DD, Foxx-Orenstein AE. Eosinophilic esophagitis: An update. Diseases Esophagus. 2007;20:2–8.CrossRef Ferguson DD, Foxx-Orenstein AE. Eosinophilic esophagitis: An update. Diseases Esophagus. 2007;20:2–8.CrossRef
10.
Zurück zum Zitat Matzineger MA, Daneman A. Esophageal involvement in eosinophilic gastroenteritis. Pediatr Radiol. 1983;13:35–38.CrossRef Matzineger MA, Daneman A. Esophageal involvement in eosinophilic gastroenteritis. Pediatr Radiol. 1983;13:35–38.CrossRef
11.
Zurück zum Zitat Gonsalves N, Anh T, Zhang Q, et al. Distinct allergic predisposition of children and adults with eosinophilic esophagitis. Gastroenterology. 2006;130:A-579. Gonsalves N, Anh T, Zhang Q, et al. Distinct allergic predisposition of children and adults with eosinophilic esophagitis. Gastroenterology. 2006;130:A-579.
12.
Zurück zum Zitat Mann NS, Leung JW. Pathogenesis of esophageal rings in eosinophilic esophagitis. Med Hypotheses 2005;64:520–523. Mann NS, Leung JW. Pathogenesis of esophageal rings in eosinophilic esophagitis. Med Hypotheses 2005;64:520–523.
13.
Zurück zum Zitat Arora AS, Perrault J, Smyrk TC. Topical corticosteroids treatment of dysphagia due to eosinophilic esophagitis in adults. Mayo Clin Proc. 2003;78:830–835.PubMedCrossRef Arora AS, Perrault J, Smyrk TC. Topical corticosteroids treatment of dysphagia due to eosinophilic esophagitis in adults. Mayo Clin Proc. 2003;78:830–835.PubMedCrossRef
14.
Zurück zum Zitat Attword SE, Smyrk TC, Demeester TR, Jones JB. Esophageal eosinophilia with dysphagia: A distinct clinicopathologic syndrome. Dig Dis Sci. 1993;38:109–116.CrossRef Attword SE, Smyrk TC, Demeester TR, Jones JB. Esophageal eosinophilia with dysphagia: A distinct clinicopathologic syndrome. Dig Dis Sci. 1993;38:109–116.CrossRef
15.
Zurück zum Zitat Ahmad M, Soetikno RM, Ahmed A. The differential diagnosis of eosinophilic esophagitis. J Clin Gastroenterol. 2000;30:242–244.PubMedCrossRef Ahmad M, Soetikno RM, Ahmed A. The differential diagnosis of eosinophilic esophagitis. J Clin Gastroenterol. 2000;30:242–244.PubMedCrossRef
16.
Zurück zum Zitat Awad ZT, Watson P, Smyrk TC, Filipi CJ. Dysphagia is associated with intraepithelial eosinophils (IEOE) in esophageal biopsies. Gastroenterology. 2000;118:A243.CrossRef Awad ZT, Watson P, Smyrk TC, Filipi CJ. Dysphagia is associated with intraepithelial eosinophils (IEOE) in esophageal biopsies. Gastroenterology. 2000;118:A243.CrossRef
17.
Zurück zum Zitat Mueller S, Aigner T, Neureiter D, Stolte M. Eosinophil infiltration and degranulation in esophageal mucosa from adult patients with eosinophilic esophagitis (EOE). A retrospective comparative pathologic biopsy study. J Clin Pathol. 2006;59:1175–1180.PubMedCrossRef Mueller S, Aigner T, Neureiter D, Stolte M. Eosinophil infiltration and degranulation in esophageal mucosa from adult patients with eosinophilic esophagitis (EOE). A retrospective comparative pathologic biopsy study. J Clin Pathol. 2006;59:1175–1180.PubMedCrossRef
18.
Zurück zum Zitat Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: A systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342–1363.PubMedCrossRef Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: A systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342–1363.PubMedCrossRef
19.
Zurück zum Zitat Prasad GA, Talley NJ, Romero Y, et al. Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: A prospective study. Am J Gastroenterology. 2007;102:2627–2632.CrossRef Prasad GA, Talley NJ, Romero Y, et al. Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: A prospective study. Am J Gastroenterology. 2007;102:2627–2632.CrossRef
20.
Zurück zum Zitat Locke GR III, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted Country, Minnesota. Gastroenterology. 1997;112:1448–1456.PubMedCrossRef Locke GR III, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted Country, Minnesota. Gastroenterology. 1997;112:1448–1456.PubMedCrossRef
21.
Zurück zum Zitat Desai TK, Stecevic V, Chang C. Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc. 2005;61:795–801.PubMedCrossRef Desai TK, Stecevic V, Chang C. Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc. 2005;61:795–801.PubMedCrossRef
22.
Zurück zum Zitat Spechler SJ, Genta RM, Souza RF. Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol. 2007;102:1301–1306.PubMedCrossRef Spechler SJ, Genta RM, Souza RF. Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol. 2007;102:1301–1306.PubMedCrossRef
23.
Zurück zum Zitat Dellon ES, Gibbs WB, Fritchie KJ, et al. Clinical, endoscopic, and histopathological findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2009;7:1305–1313.PubMedCrossRef Dellon ES, Gibbs WB, Fritchie KJ, et al. Clinical, endoscopic, and histopathological findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2009;7:1305–1313.PubMedCrossRef
24.
Zurück zum Zitat Peterson KA, Thomas KL, Hilden K, et al. Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis. Dig Dis Sci. 2010;55:1313–1319. Peterson KA, Thomas KL, Hilden K, et al. Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis. Dig Dis Sci. 2010;55:1313–1319.
25.
Zurück zum Zitat Molina-Infante J, Ferrando-Lamana L, Ripoll C, et al. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol. 2010 [Epub ahead of print]. Molina-Infante J, Ferrando-Lamana L, Ripoll C, et al. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol. 2010 [Epub ahead of print].
26.
Zurück zum Zitat Gonsalves N, Policarpio-Nicolas M, Zhang Q, Rao MS, Hirano I. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc. 2006;64:313–319.PubMedCrossRef Gonsalves N, Policarpio-Nicolas M, Zhang Q, Rao MS, Hirano I. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc. 2006;64:313–319.PubMedCrossRef
27.
Zurück zum Zitat Orenstein S, Shalaby T, Lorenzo C, et al. The spectrum of pediatric eosinophilic esophagitis beyond infancy: A clinical series of 30 children. Am J Gastroenterol. 2000;95:1422–1430.PubMedCrossRef Orenstein S, Shalaby T, Lorenzo C, et al. The spectrum of pediatric eosinophilic esophagitis beyond infancy: A clinical series of 30 children. Am J Gastroenterol. 2000;95:1422–1430.PubMedCrossRef
28.
Zurück zum Zitat Noel R, Putnam P, Collins M, et al. Clinical and Immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2004;2:568–575.PubMedCrossRef Noel R, Putnam P, Collins M, et al. Clinical and Immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2004;2:568–575.PubMedCrossRef
29.
Zurück zum Zitat Liacouras CA, Spergel JM, Ruchelli E, Verma R, Mascarenhas M, et al. Eosinophilic esophagitis: A 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3:1198–1206.PubMedCrossRef Liacouras CA, Spergel JM, Ruchelli E, Verma R, Mascarenhas M, et al. Eosinophilic esophagitis: A 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3:1198–1206.PubMedCrossRef
Metadaten
Titel
Low Grade Esophageal Eosinophilia in Adults: An Unrecognized Part of the Spectrum of Eosinophilic Esophagitis?
verfasst von
Karthik Ravi
Nicholas J. Talley
Thomas C. Smyrk
David A. Katzka
Lori Kryzer
Yvonne Romero
Amindra S. Arora
Jeffrey A. Alexander
Publikationsdatum
01.07.2011
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 7/2011
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-1594-1

Weitere Artikel der Ausgabe 7/2011

Digestive Diseases and Sciences 7/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.